The Bioequivalence of Tafamidis 61‐mg Free Acid Capsules and Tafamidis Meglumine 4 × 20‐mg Capsules in Healthy Volunteers

Tafamidis, a non‐nonsteroidal anti‐inflammatory benzoxazole derivative, acts as a transthyretin (TTR) stabilizer to slow progression of TTR amyloidosis (ATTR). Tafamidis meglumine, available as 20‐mg capsules, is approved in more than 40 countries worldwide for the treatment of adults with early‐sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Lockwood, Peter A., Le, Vu H., O'Gorman, Melissa T., Patterson, Terrell A., Sultan, Marla B., Tankisheva, Ekaterina, Wang, Qiang, Riley, Steve
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754314/
https://www.ncbi.nlm.nih.gov/pubmed/32196976
http://dx.doi.org/10.1002/cpdd.789

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754314/
https://www.ncbi.nlm.nih.gov/pubmed/32196976
http://dx.doi.org/10.1002/cpdd.789

Ejemplares similares